Investigating the Role of 13cis Retinoic Acid in the Treatment of COVID-19 and Enhancement of Its Spike Protein Based Vaccine Efficacy and Safety.
Clinical trial NCT04730895 · UNKNOWN
Trial details
- NCT number
- NCT04730895
- Sponsor
- Kafrelsheikh University
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-01
- Primary completion
- 2021-09-01
- Enrollment
- 360
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.